Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Equity

v3.21.4
Consolidated Statements of Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholders Equity [Member]
Noncontrolling Interest [Member]
BALANCE, October 31, 2020 at Oct. 31, 2019 $ 4,812,378 $ 203,317 $ 186,849,299 $ (181,817,263) $ 5,235,353 $ (422,975)
Beginning balance, shares at Oct. 31, 2019   20,331,754        
Stock option compensation to employees and directors 3,922,719 3,922,719 3,922,719
Stock options and warrants issued to consultants 214,741 214,741   214,741
Common stock issued upon exercise of stock options 122,270 $ 511 121,759 122,270
Common stock issued upon exercise of stock options, shares   51,100        
Common stock issued pursuant to employee stock purchase plan 18,451 $ 115 18,336 18,451
Common stock issued pursuant to employee stock purchase plan, shares   11,536        
Common stock issued in an at-the-market offering, net of offering expenses of $340,775 9,266,177 $ 38,543 9,227,634 9,266,177
Common stock issued in at-the-market offering, net of offering expenses, shares   3,854,305        
Net Loss (10,092,363) (10,018,355) (10,018,355) (74,008)
BALANCE, October 31, 2021 at Oct. 31, 2020 8,264,373 $ 242,486 200,354,488 (191,835,618) 8,761,356 (496,983)
Ending balance, shares at Oct. 31, 2020   24,248,695        
Stock option compensation to employees and directors 7,503,037 7,503,037 7,503,037
Expired restricted stock award to employee $ (15,000) 15,000
Expired restricted stock award to employee ,shares   (1,500,000)        
Stock options and warrants issued to consultants 555,041 555,041 555,041
Common stock issued upon exercise of stock options $ 434,224 $ 2,077 432,147 434,224
Common stock issued upon exercise of stock options, shares 56,000 207,697        
Common stock issued pursuant to employee stock purchase plan $ 6,000 $ 24 5,976 6,000
Common stock issued pursuant to employee stock purchase plan, shares   2,377        
Common stock issued in a public offering, net of offering expenses of $2,208,150 20,291,854 $ 42,858 20,248,996 20,291,854
Common stock issued in a public offering, net of offering expenses, shares   4,285,715        
Common stock issued in an at-the-market offering, net of offering expenses of $340,775 10,833,715 $ 28,064 10,805,651 10,833,715
Common stock issued in at-the-market offering, net of offering expenses, shares   2,806,410        
Proceeds received on sale of common stock held by ZQX Advisors, LLC 6,473 6,473 6,473
Net Loss (13,127,923) (12,954,400) (12,954,400) (173,523)
BALANCE, October 31, 2021 at Oct. 31, 2021 $ 34,766,794 $ 300,509 $ 239,926,809 $ (204,790,018) $ 35,437,300 $ (670,506)
Ending balance, shares at Oct. 31, 2021   30,050,894